This post-approval study has not been publically released by the fda. It may be a place-holder supplement number.
Device | P010051S002 |
Classification Name | None |
Applicant | |
PMA | P010051 |
Supplement | S002 |
Supplement Number | Date | Supplement Type |
---|---|---|
P010051 | Original Filing | |
S017 | 2022-09-15 | 30-day Notice |
S016 | ||
S015 | 2022-02-28 | 30-day Notice |
S014 | 2020-12-22 | Real-time Process |
S013 | 2020-08-12 | 30-day Notice |
S012 | 2019-11-25 | 30-day Notice |
S011 | 2011-12-19 | 135 Review Track For 30-day Notice |
S010 | 2011-08-16 | 30-day Notice |
S009 | 2011-08-08 | 30-day Notice |
S008 | 2011-02-18 | Real-time Process |
S007 | 2009-11-02 | Normal 180 Day Track No User Fee |
S006 | ||
S005 | 2008-11-10 | Normal 180 Day Track No User Fee |
S004 | 2005-12-22 | Real-time Process |
S003 | 2005-08-17 | Special (immediate Track) |
S002 | ||
S001 | 2002-11-20 | Real-time Process |
Device ID | PMA | Supp |
---|---|---|
00630414970981 | P010051 | 001 |
00630414970974 | P010051 | 001 |